Antibody dramatically reduces amyloid plaques in Alzheimer’s patient study

A potential game-changer in the fight against Alzheimer’s Disease has been successfully trialled. Biogen developed aducanumab was found to almost completely clear the visible signs of Alzheimer’s disease from the brain.

165 patient brains were scanned as they were given the drug. After a year, almost all of the amyloid plaques appeared to have disappeared from those given the highest doses.

The findings suggest the plaques at least partly cause the disease, and are not a byproduct.  This has long been debated.

The drug is not with out risk, however.  It caused brain swelling in some patients, who then ledt the trial.


Wearable Tech + Digital Health + NeuroTech Silicon Valley – February 7-8 @ Stanford University – Featuring:   Vinod Khosla – Tom Insel – Zhenan Bao – Phillip Alvelda – Nathan Intrator – John Rogers – Mary Lou Jepsen – Vivek Wadhwa – Miguel Nicolelis